Cutler Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,500
| Closed | -$265K | – | 1295 |
|
|
2023
Q3 | $265K | Buy |
+1,500
| New | +$265K | 0.03% | 346 |
|
|
2023
Q2 | – | Sell |
-600
| Closed | -$120K | – | 1360 |
|
|
2023
Q1 | $120K | Buy |
+600
| New | +$120K | 0.01% | 452 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1720 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1888 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1869 |
|
|
2022
Q1 | – | Sell |
-11,582
| Closed | -$1.96M | – | 1940 |
|
|
2021
Q4 | $1.96M | Buy |
+11,582
| New | +$1.96M | 0.08% | 157 |
|
|
2021
Q3 | – | Sell |
-1,200
| Closed | -$203K | – | 2081 |
|
|
2021
Q2 | $203K | Buy |
+1,200
| New | +$203K | 0.01% | 730 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1524 |
|
|
2020
Q1 | – | Sell |
-3,900
| Closed | -$449K | – | 1408 |
|
|
2019
Q4 | $449K | Buy |
3,900
+363
| +10% | +$41.8K | 0.03% | 334 |
|
|
2019
Q3 | $284K | Sell |
3,537
-1,900
| -35% | -$153K | 0.03% | 348 |
|
|
2019
Q2 | $394K | Buy |
5,437
+2,937
| +117% | +$213K | 0.04% | 287 |
|
|
2019
Q1 | $233K | Sell |
2,500
-175
| -7% | -$16.3K | 0.02% | 405 |
|
|
2018
Q4 | $195K | Sell |
2,675
-206
| -7% | -$15K | 0.02% | 403 |
|
|
2018
Q3 | $252K | Sell |
2,881
-900
| -24% | -$78.7K | 0.02% | 502 |
|
|
2018
Q2 | $372K | Sell |
3,781
-910
| -19% | -$89.5K | 0.03% | 391 |
|
|
2018
Q1 | $558K | Sell |
4,691
-39,944
| -89% | -$4.75M | 0.05% | 271 |
|
|
2017
Q4 | $5.67M | Buy |
44,635
+1,876
| +4% | +$238K | 0.23% | 45 |
|
|
2017
Q3 | $5.02M | Buy |
42,759
+12,471
| +41% | +$1.46M | 0.19% | 63 |
|
|
2017
Q2 | $2.42M | Buy |
30,288
+4,128
| +16% | +$329K | 0.09% | 141 |
|
|
2017
Q1 | $1.34M | Buy |
26,160
+6,728
| +35% | +$345K | 0.06% | 227 |
|
|
2016
Q4 | $727K | Buy |
19,432
+6,882
| +55% | +$257K | 0.03% | 369 |
|
|
2016
Q3 | $850K | Sell |
12,550
-4,535
| -27% | -$307K | 0.04% | 268 |
|
|
2016
Q2 | $948K | Buy |
17,085
+12,529
| +275% | +$695K | 0.05% | 201 |
|
|
2016
Q1 | $285K | Buy |
4,556
+2,538
| +126% | +$159K | 0.02% | 480 |
|
|
2015
Q4 | $189K | Buy |
+2,018
| New | +$189K | 0.01% | 733 |
|